Skip to main content
. 2020 Aug 11;9(8):2600. doi: 10.3390/jcm9082600

Figure 2.

Figure 2

Efficacy clinical outcomes for patients in the propensity-score matched cohort by groups (SGLT-2 inhibitors/non-SGLT-2 inhibitors). CI: confidence interval; CV: cardiovascular; HR: hazard ratio; SGLT-2i: sodium-glucose cotransporter-2 inhibitors.